Our team

AlphaNet Canada relies on a dedicated staff and Board of Directors who are committed to our mission of improving the lives of individuals affected by alpha-1 antitrypsin deficiency.

The AlphaNet team

AlphaNet Canada is governed by a Board of Directors chaired by Robert L. Greene, Jr. and operations are managed by Mark Delvaux, Chief Executive Officer.

Dr. Kenneth Chapman leads the organization’s medical direction in partnership with Dr. Robert Sandhaus.

Angela Diano, Executive Director, spearheads Canadian Alpha-1 advocacy efforts, working alongside Mike Benn, Program Manager, and the national team of AlphaNet Canada Coordinators.

For more information about our team of AlphaNet Coordinators, visit CONNECT WITH A COORDINATOR.

Leadership & staff

Angela Diano
Angela DianoExecutive Director
Mark Delvaux
Mark DelvauxChief Executive Officer
Kenneth Chapman, MD, MSc, FRCPC, FACP, FCCP, FERS
Kenneth Chapman, MD, MSc, FRCPC, FACP, FCCP, FERSMedical Director & Board Member
Robert Sandhaus, MD, PhD, FCCP
Robert Sandhaus, MD, PhD, FCCPMedical Director
Mike Benn
Mike BennProgram Manager

Board of Directors

Robert Greene, Jr.
Robert Greene, Jr.Board Chair
Michael Johnson
Michael JohnsonBoard Treasurer
Vivien Rossi, RN
Vivien Rossi, RNBoard Secretary
Kenneth Chapman, MD, MSc, FRCPC, FACP, FCCP, FERS
Kenneth Chapman, MD, MSc, FRCPC, FACP, FCCP, FERSBoard Member
Randel Plant
Randel PlantBoard Member